TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.0114466139245207	-4.47006131983387	8	4	0.0347826086956522	115	907	4122,11320,4249,11282	MAN2A2,MGAT4A,MGAT5,MGAT4B
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.0132728455693175	-4.32203501735509	66	15	0.130434782608696	115	907	5335,23007,5728,90809,3635,5295,5336,79837,5290,5287,5293,200576,3706,9562,5330	PLCG1,PLCH1,PTEN,TMEM55B,INPP5D,PIK3R1,PLCG2,PIP4K2C,PIK3CA,PIK3C2B,PIK3CD,PIKFYVE,ITPKA,MINPP1,PLCB2
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.0138779744234178	-4.27745226946528	17	6	0.0521739130434783	115	907	5335,23007,5330,90809,5336,79837	PLCG1,PLCH1,PLCB2,TMEM55B,PLCG2,PIP4K2C
META_PWY-4041	gamma-glutamyl cycle	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	2730,2729	GCLM,GCLC
META_PWY-5340	sulfate activation for sulfonation	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	9060,9061	PAPSS2,PAPSS1
HUMAN_PWY-5340	sulfate activation for sulfonation	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	9060,9061	PAPSS2,PAPSS1
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	501,10157	ALDH7A1,AASS
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	55907,54187	CMAS,NANS
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.0159539125419012	-4.13805117939984	2	2	0.0173913043478261	115	907	501,10157	ALDH7A1,AASS
HUMAN_PWY-0	putrescine degradation III	0.018608796497293	-3.98412088009712	9	4	0.0347826086956522	115	907	221,217,224,6303	ALDH3B1,ALDH2,ALDH3A2,SAT1
HUMAN_PWY-6398	melatonin degradation I	0.0280241155698801	-3.57468986913456	10	4	0.0347826086956522	115	907	113612,5447,29785,1545	CYP2U1,POR,CYP2S1,CYP1B1
META_PWY-5327	superpathway of L-lysine degradation	0.0297898293656564	-3.51358824018015	6	3	0.0260869565217391	115	907	501,1428,10157	ALDH7A1,CRYM,AASS
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0316024420932735	-3.45452087994262	15	5	0.0434782608695652	115	907	337876,29940,64132,64131,79586	CHSY3,DSE,XYLT2,XYLT1,CHPF
META_PWY-6571	dermatan sulfate biosynthesis	0.0316024420932735	-3.45452087994262	15	5	0.0434782608695652	115	907	337876,29940,64132,64131,79586	CHSY3,DSE,XYLT2,XYLT1,CHPF
HUMAN_PWY-6402	superpathway of melatonin degradation	0.0398101337113056	-3.22363378323891	11	4	0.0347826086956522	115	907	113612,5447,29785,1545	CYP2U1,POR,CYP2S1,CYP1B1
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.0438776666483033	-3.12634982073413	3	2	0.0173913043478261	115	907	2805,4190	GOT1,MDH1
META_PWY-0	putrescine degradation III	0.0438776666483033	-3.12634982073413	3	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.0438776666483033	-3.12634982073413	3	2	0.0173913043478261	115	907	501,1428	ALDH7A1,CRYM
HUMAN_PWY66-221	nicotine degradation III	0.0473774293980824	-3.04960933672373	7	3	0.0260869565217391	115	907	113612,29785,316	CYP2U1,CYP2S1,AOX1
META_PWY-6564	heparan sulfate biosynthesis	0.0597379103462244	-2.81778844594515	23	6	0.0521739130434783	115	907	9394,9953,9348,64132,64131,26035	HS6ST1,HS3ST3B1,NDST3,XYLT2,XYLT1,GLCE
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.0689359186823179	-2.67457792065663	8	3	0.0260869565217391	115	907	231,113612,29785	AKR1B1,CYP2U1,CYP2S1
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY66-21	ethanol degradation II	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY66-162	ethanol degradation IV	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	1890,978	TYMP,CDA
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	6470,63826	SHMT1,SRR
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	4190,2805	MDH1,GOT1
META_PWY66-161	oxidative ethanol degradation III	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-5874	heme degradation	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	644,645	BLVRA,BLVRB
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	8309,5447	ACOX2,POR
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.0805275939139863	-2.51915537175359	4	2	0.0173913043478261	115	907	501,1428	ALDH7A1,CRYM
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.0808713402988361	-2.51489577851309	19	5	0.0434782608695652	115	907	3706,9562,5728,54928,3635	ITPKA,MINPP1,PTEN,IMPAD1,INPP5D
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.0940994797750825	-2.36340276083241	9	3	0.0260869565217391	115	907	5330,90809,5336	PLCB2,TMEM55B,PLCG2
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.0973166560989165	-2.32978512151208	20	5	0.0434782608695652	115	907	3706,9562,5728,54928,3635	ITPKA,MINPP1,PTEN,IMPAD1,INPP5D
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.0993677509098006	-2.30892765548801	26	6	0.0521739130434783	115	907	9394,9953,9348,64132,64131,26035	HS6ST1,HS3ST3B1,NDST3,XYLT2,XYLT1,GLCE
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.110516199508379	-2.20259316688355	15	4	0.0347826086956522	115	907	3706,9562,5728,3635	ITPKA,MINPP1,PTEN,INPP5D
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.110516199508379	-2.20259316688355	15	4	0.0347826086956522	115	907	3706,9562,5728,3635	ITPKA,MINPP1,PTEN,INPP5D
HUMAN_PWY66-201	nicotine degradation IV	0.122417493006039	-2.10031800239953	10	3	0.0260869565217391	115	907	113612,29785,316	CYP2U1,CYP2S1,AOX1
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	1633,978	DCK,CDA
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	6482,2650	ST3GAL1,GCNT1
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	1890,978	TYMP,CDA
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	5625,4942	PRODH,OAT
META_PWY-6566	chondroitin biosynthesis	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	337876,79586	CHSY3,CHPF
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	337876,79586	CHSY3,CHPF
META_PWY-6313	serotonin degradation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-6398	melatonin degradation I	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	5447,1545	POR,CYP1B1
META_PWY-6402	superpathway of melatonin degradation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	5447,1545	POR,CYP1B1
HUMAN_PWY66-21	ethanol degradation II	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-162	ethanol degradation IV	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-241	bupropion degradation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	113612,29785	CYP2U1,CYP2S1
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	2673,6675	GFPT1,UAP1
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	1633,978	DCK,CDA
HUMAN_PWY-5030	histidine degradation	0.123279077915	-2.09330456759753	5	2	0.0173913043478261	115	907	144193,3034	AMDHD1,HAL
META_PWY-5329	L-cysteine degradation III	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	2805	GOT1
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	2805	GOT1
META_PWY66-389	phytol degradation	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	224	ALDH3A2
META_HISHP-PWY	L-histidine degradation VI	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	3034	HAL
META_PWY6666-1	anandamide degradation	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	2166	FAAH
HUMAN_PWY-5329	L-cysteine degradation II	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	2805	GOT1
HUMAN_PWY66-389	phytol degradation	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	224	ALDH3A2
HUMAN_PWY-2161B	glutamate removal from folates	0.126791620727799	-2.0652103217509	1	1	0.00869565217391304	115	907	8836	GGH
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.155659074636172	-1.86008708224454	23	5	0.0434782608695652	115	907	5335,23007,5330,5336,79837	PLCG1,PLCH1,PLCB2,PLCG2,PIP4K2C
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.158362279493699	-1.84286996246981	17	4	0.0347826086956522	115	907	9394,9953,9348,26035	HS6ST1,HS3ST3B1,NDST3,GLCE
META_PWY-6342	noradrenaline and adrenaline degradation	0.170023702189837	-1.77181742700449	6	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.170023702189837	-1.77181742700449	6	2	0.0173913043478261	115	907	64132,64131	XYLT2,XYLT1
HUMAN_PWY66-161	oxidative ethanol degradation III	0.170023702189837	-1.77181742700449	6	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.170023702189837	-1.77181742700449	6	2	0.0173913043478261	115	907	64132,64131	XYLT2,XYLT1
META_PWY-6569	chondroitin sulfate biosynthesis	0.184736492719365	-1.68882483295315	18	4	0.0347826086956522	115	907	337876,64132,64131,79586	CHSY3,XYLT2,XYLT1,CHPF
META_PWY-6352	3-phosphoinositide biosynthesis	0.200978182624344	-1.6045589209719	25	5	0.0434782608695652	115	907	5287,5293,200576,5295,5290	PIK3C2B,PIK3CD,PIKFYVE,PIK3R1,PIK3CA
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.200978182624344	-1.6045589209719	25	5	0.0434782608695652	115	907	2591,51809,6482,79695,2650	GALNT3,GALNT7,ST3GAL1,GALNT12,GCNT1
META_PWY-6368	3-phosphoinositide degradation	0.21243386669835	-1.54912455459245	19	4	0.0347826086956522	115	907	5728,3635,90809,8821	PTEN,INPP5D,TMEM55B,INPP4B
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.21243386669835	-1.54912455459245	19	4	0.0347826086956522	115	907	337876,64132,64131,79586	CHSY3,XYLT2,XYLT1,CHPF
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.219082211307002	-1.51830822551247	7	2	0.0173913043478261	115	907	501,6470	ALDH7A1,SHMT1
HUMAN_PWY-6313	serotonin degradation	0.219082211307002	-1.51830822551247	7	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-6076	vitamin D3 biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	5447	POR
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	9562	MINPP1
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	501	ALDH7A1
HUMAN_PWY0-662	PRPP biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	5634	PRPS2
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	5447	POR
META_PWY-6117	spermine and spermidine degradation I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	6303	SAT1
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	978	CDA
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	4329	ALDH6A1
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	54187	NANS
META_PWY-5874	heme degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	644	BLVRA
HUMAN_PWY6666-1	anandamide degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2166	FAAH
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2805	GOT1
META_PWY-5030	L-histidine degradation III	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	3034	HAL
HUMAN_PWY-5386	methylglyoxal degradation I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2739	GLO1
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	6470	SHMT1
HUMAN_PWY-4041	gamma-glutamyl cycle	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	26873	OPLAH
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2805	GOT1
META_PWY0-662	PRPP biosynthesis I	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	5634	PRPS2
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	54187	NANS
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	224	ALDH3A2
META_PWY66-388	fatty acid alpha-oxidation III	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	224	ALDH3A2
META_PWY-5453	methylglyoxal degradation III	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	231	AKR1B1
META_PROUT-PWY	L-proline degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	5625	PRODH
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	6470	SHMT1
META_PWY-7343	UDP-glucose biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	7360	UGP2
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2805	GOT1
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	501	ALDH7A1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.237629328909761	-1.43704326093912	2	1	0.00869565217391304	115	907	2673	GFPT1
HUMAN_PWY-6368	3-phosphoinositide degradation	0.241213169348461	-1.42207421633079	20	4	0.0347826086956522	115	907	5728,3635,90809,8821	PTEN,INPP5D,TMEM55B,INPP4B
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.241213169348461	-1.42207421633079	20	4	0.0347826086956522	115	907	9394,9953,9348,26035	HS6ST1,HS3ST3B1,NDST3,GLCE
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.250192919194712	-1.38552298193048	27	5	0.0434782608695652	115	907	5287,5293,200576,5295,5290	PIK3C2B,PIK3CD,PIKFYVE,PIK3R1,PIK3CA
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.254062010711042	-1.37017690510246	34	6	0.0521739130434783	115	907	217,113612,224,5447,29785,1545	ALDH2,CYP2U1,ALDH3A2,POR,CYP2S1,CYP1B1
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.269130975515547	-1.31255712004927	8	2	0.0173913043478261	115	907	6675,10007	UAP1,GNPDA1
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.293943713023238	-1.2243669822747	15	3	0.0260869565217391	115	907	129607,1633,978	CMPK2,DCK,CDA
HUMAN_LIPASYN-PWY	phospholipases	0.302127539931477	-1.19690603310437	29	5	0.0434782608695652	115	907	5335,23007,5337,5330,5336	PLCG1,PLCH1,PLD1,PLCB2,PLCG2
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	6697	SPR
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	978	CDA
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	4942	OAT
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9562	MINPP1
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	978	CDA
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	224	ALDH3A2
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	2805	GOT1
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9415	FADS2
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9415	FADS2
META_PWY6666-2	dopamine degradation	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	224	ALDH3A2
META_PWY-6875	retinoate biosynthesis II	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	7498	XDH
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9562	MINPP1
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	4942	OAT
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	231	AKR1B1
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	6697	SPR
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	6697	SPR
META_PWY-2301	myo-inositol biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	54928	IMPAD1
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	978	CDA
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	2235	FECH
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9415	FADS2
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	10007	GNPDA1
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	4942	OAT
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	231	AKR1B1
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	2235	FECH
HUMAN_PWY-5453	methylglyoxal degradation III	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	231	AKR1B1
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	32	ACACB
META_PWY66-221	nicotine degradation V	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	316	AOX1
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.334505160045246	-1.0951029733886	3	1	0.00869565217391304	115	907	9415	FADS2
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	0.36832059462279	-0.998801539030966	10	2	0.0173913043478261	115	907	217,224	ALDH2,ALDH3A2
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.36832059462279	-0.998801539030966	10	2	0.0173913043478261	115	907	1633,978	DCK,CDA
META_PWY-5004	superpathway of L-citrulline metabolism	0.416081781707401	-0.876873447399492	11	2	0.0173913043478261	115	907	5625,4942	PRODH,OAT
META_PWY66-368	ketolysis	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	622	BDH1
HUMAN_PWY6666-2	dopamine degradation	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	224	ALDH3A2
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	9562	MINPP1
HUMAN_PWY-6117	spermine and spermidine degradation I	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	6303	SAT1
HUMAN_PWY-2161	folate polyglutamylation	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	6470	SHMT1
HUMAN_PWY66-368	ketolysis	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	622	BDH1
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	29940	DSE
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	2805	GOT1
HUMAN_PWY66-367	ketogenesis	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	622	BDH1
META_PWY-6608	guanosine nucleotides degradation III	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	7498	XDH
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	224	ALDH3A2
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	29940	DSE
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	2950	GSTP1
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	224	ALDH3A2
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	10007	GNPDA1
META_PWY66-387	fatty acid alpha-oxidation II	0.419164348756983	-0.869492195496056	4	1	0.00869565217391304	115	907	224	ALDH3A2
HUMAN_PWY-4061	glutathione-mediated detoxification	0.440612623421589	-0.819589194498691	19	3	0.0260869565217391	115	907	8836,4258,2950	GGH,MGST2,GSTP1
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.440612623421589	-0.819589194498691	19	3	0.0260869565217391	115	907	205,122481,10476	AK4,AK7,ATP5H
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.461993288891353	-0.772204914215098	12	2	0.0173913043478261	115	907	8309,5447	ACOX2,POR
HUMAN_PWY-7511	protein ubiquitylation	0.483630879282485	-0.726433309338561	28	4	0.0347826086956522	115	907	92912,29089,55293,51465	UBE2Q2,UBE2T,UEVLD,UBE2J1
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	10555	AGPAT2
HUMAN_PWY66-375	leukotriene biosynthesis	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	4048	LTA4H
HUMAN_PWY-3661-1	glycine betaine degradation	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	6470	SHMT1
META_PWY66-375	leukotriene biosynthesis	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	4048	LTA4H
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	53354	PANK1
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	221	ALDH3B1
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	6470	SHMT1
META_PWY-6111	mitochondrial L-carnitine shuttle	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	1376	CPT2
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	2184	FAH
META_PWY66-367	ketogenesis	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	622	BDH1
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	7498	XDH
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	2184	FAH
META_PWY-6074	zymosterol biosynthesis	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	3930	LBR
META_PWY66-201	nicotine degradation IV	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	316	AOX1
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	250	ALPP
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	53354	PANK1
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	1376	CPT2
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	978	CDA
META_PWY-4081	glutathione redox reactions I	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	2879	GPX4
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.493135666468463	-0.706970957261634	5	1	0.00869565217391304	115	907	32	ACACB
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.505754953026871	-0.681703009552933	13	2	0.0173913043478261	115	907	337876,79586	CHSY3,CHPF
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.505754953026871	-0.681703009552933	13	2	0.0173913043478261	115	907	5330,5336	PLCB2,PLCG2
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	9517	SPTLC2
META_PWY3DJ-12	ceramide de novo biosynthesis	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	9517	SPTLC2
HUMAN_PWY-6074	zymosterol biosynthesis	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	3930	LBR
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	7498	XDH
HUMAN_PWY-4081	glutathione redox reactions I	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	2879	GPX4
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	978	CDA
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.5577580593258	-0.583829996063805	6	1	0.00869565217391304	115	907	9517	SPTLC2
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.58612913277978	-0.534215150576081	15	2	0.0173913043478261	115	907	3706,3635	ITPKA,INPP5D
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.58612913277978	-0.534215150576081	15	2	0.0173913043478261	115	907	3706,3635	ITPKA,INPP5D
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	2235	FECH
META_LEU-DEG2-PWY	L-leucine degradation I	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	64087	MCCC2
META_PWY-6872	retinoate biosynthesis I	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	220	ALDH1A3
META_PWY-7224	purine deoxyribonucleosides salvage	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	1633	DCK
HUMAN_PWY-5920	heme biosynthesis	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	2235	FECH
HUMAN_PWY-5067	glycogen biosynthesis	0.614204033997537	-0.4874281031078	7	1	0.00869565217391304	115	907	7360	UGP2
HUMAN_PWY66-399	gluconeogenesis	0.622582118364826	-0.473879742291634	16	2	0.0173913043478261	115	907	4190,2026	MDH1,ENO2
META_PWY66-399	gluconeogenesis III	0.622582118364826	-0.473879742291634	16	2	0.0173913043478261	115	907	4190,2026	MDH1,ENO2
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.633821145730683	-0.455988468869614	25	3	0.0260869565217391	115	907	10555,9890,8613	AGPAT2,PLPPR4,PLPP3
HUMAN_PWY-2201	folate transformations I	0.66350018521004	-0.410226146068935	8	1	0.00869565217391304	115	907	6470	SHMT1
HUMAN_PWY-6872	retinoate biosynthesis I	0.66350018521004	-0.410226146068935	8	1	0.00869565217391304	115	907	220	ALDH1A3
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.706545211575779	-0.347368085167233	9	1	0.00869565217391304	115	907	79868	ALG13
HUMAN_PWY-7205	CMP phosphorylation	0.706545211575779	-0.347368085167233	9	1	0.00869565217391304	115	907	129607	CMPK2
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.706545211575779	-0.347368085167233	9	1	0.00869565217391304	115	907	427	ASAH1
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.706545211575779	-0.347368085167233	9	1	0.00869565217391304	115	907	7498	XDH
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.717135343696856	-0.332490692323293	19	2	0.0173913043478261	115	907	10555,1040	AGPAT2,CDS1
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.744125724572371	-0.295545273785058	10	1	0.00869565217391304	115	907	9415	FADS2
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.744125724572371	-0.295545273785058	10	1	0.00869565217391304	115	907	129607	CMPK2
META_PWY66-341	cholesterol biosynthesis I	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	3930	LBR
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	3930	LBR
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	54928	IMPAD1
HUMAN_LEU-DEG2-PWY	leucine degradation	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	64087	MCCC2
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	3930	LBR
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	26090	ABHD12
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	1633	DCK
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.776930118859529	-0.252404869776798	11	1	0.00869565217391304	115	907	129607	CMPK2
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.805560739767897	-0.216216672916403	12	1	0.00869565217391304	115	907	8309	ACOX2
HUMAN_VALDEG-PWY	valine degradation	0.805560739767897	-0.216216672916403	12	1	0.00869565217391304	115	907	4329	ALDH6A1
META_PWY-6857	retinol biosynthesis	0.805560739767897	-0.216216672916403	12	1	0.00869565217391304	115	907	9249	DHRS3
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.805560739767897	-0.216216672916403	12	1	0.00869565217391304	115	907	36	ACADSB
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.805560739767897	-0.216216672916403	12	1	0.00869565217391304	115	907	9415	FADS2
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	129607	CMPK2
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	3930	LBR
HUMAN_PWY66-341	cholesterol biosynthesis I	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	3930	LBR
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	3930	LBR
META_PWY-6861	the visual cycle I (vertebrates)	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	9249	DHRS3
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	8309	ACOX2
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.830544555331467	-0.18567370256414	13	1	0.00869565217391304	115	907	54928	IMPAD1
HUMAN_PWY-5328	superpathway of methionine degradation	0.852342515217911	-0.159766819771902	14	1	0.00869565217391304	115	907	2805	GOT1
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.852342515217911	-0.159766819771902	14	1	0.00869565217391304	115	907	2805	GOT1
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.870035108780092	-0.139221713228099	37	3	0.0260869565217391	115	907	205,122481,10476	AK4,AK7,ATP5H
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.87135775682298	-0.137702643840191	15	1	0.00869565217391304	115	907	2026	ENO2
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.87135775682298	-0.137702643840191	15	1	0.00869565217391304	115	907	9249	DHRS3
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.881803002720531	-0.125786600846892	38	3	0.0260869565217391	115	907	205,122481,10476	AK4,AK7,ATP5H
META_PWY66-398	TCA cycle III (animals)	0.887942799387709	-0.11884795316864	16	1	0.00869565217391304	115	907	4190	MDH1
HUMAN_PWY66-398	TCA cycle	0.887942799387709	-0.11884795316864	16	1	0.00869565217391304	115	907	4190	MDH1
META_PWY66-400	glycolysis VI (metazoan)	0.902405849975861	-0.102690915573339	17	1	0.00869565217391304	115	907	2026	ENO2
HUMAN_PWY66-400	glycolysis	0.902405849975861	-0.102690915573339	17	1	0.00869565217391304	115	907	2026	ENO2
HUMAN_PWY-6857	retinol biosynthesis	0.902405849975861	-0.102690915573339	17	1	0.00869565217391304	115	907	9249	DHRS3
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.935591792960077	-0.0665760162643312	20	1	0.00869565217391304	115	907	129607	CMPK2
META_PWY66-5	superpathway of cholesterol biosynthesis	0.957557300302789	-0.043369716059631	23	1	0.00869565217391304	115	907	3930	LBR
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.965017171130459	-0.035609383883887	38	2	0.0173913043478261	115	907	4190,2026	MDH1,ENO2
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.967887243081161	-0.0326396829106856	25	1	0.00869565217391304	115	907	3930	LBR
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6620	guanine and guanosine salvage	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-397	resolvin D biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-7511	protein ubiquitylation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6181	histamine degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_SERDEG-PWY	L-serine degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-5670	epoxysqualene biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6181	histamine degradation	0.999999999995892	-4.10766906600024e-12	2	0	0	115	907
META_PWY-6823	molybdenum cofactor biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-7434	terminal O-glycans residues modification	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-7205	CMP phosphorylation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-3781	aerobic respiration I (cytochrome c)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5177	glutaryl-CoA degradation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-6292	cysteine biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-4921	protein citrullination	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5661	GDP-glucose biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-4984	urea cycle	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-4261	glycerol degradation	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999998821	-1.17921259779399e-12	4	0	0	115	907
META_PWY66-382	mineralocorticoid biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-5331	taurine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-6609	adenine and adenosine salvage III	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-5331	taurine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_GLYCLEAV-PWY	glycine cleavage	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY66-392	lipoxin biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-6875	retinoate biosynthesis II	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-6430	thymine degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY66-381	glucocorticoid biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY66-301	catecholamine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-6100	L-carnitine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY0-1296	purine ribonucleosides degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-3982	uracil degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY0-1182	trehalose degradation	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-6100	L-carnitine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-7177	UTP and CTP dephosphorylation II	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-7527	L-methionine salvage cycle III	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-6609	adenine and adenosine salvage III	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-3982	uracil degradation I (reductive)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_GLUDEG-I-PWY	GABA shunt	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY66-392	lipoxin biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY-7283	wybutosine biosynthesis	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY-7185	UTP and CTP dephosphorylation I	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.99999999999926	-7.39602389748795e-13	3	0	0	115	907
HUMAN_PWY66-380	estradiol biosynthesis I	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-4983	L-citrulline-nitric oxide cycle	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_VALDEG-PWY	L-valine degradation I	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-4061	glutathione-mediated detoxification I	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-4921	protein citrullination	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-4984	urea cycle	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.999999999999908	-9.20593218626739e-14	5	0	0	115	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_P121-PWY	adenine and adenosine salvage I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5686	UMP biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6399	melatonin degradation II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5905	hypusine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-46	putrescine biosynthesis III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6898	thiamin salvage III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6132	lanosterol biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5326	sulfite oxidation IV	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6938	NADH repair	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7299	progesterone biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5326	sulfite oxidation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY0-1305	glutamate dependent acid resistance	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_GLNSYN-PWY	L-glutamine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_SERDEG-PWY	L-serine degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-40	putrescine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7306	estradiol biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6619	adenine and adenosine salvage VI	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5766	L-glutamate degradation X	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY66-241	bupropion degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY66-366	flavin biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7344	UDP-D-galactose biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6938	NADH repair	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6132	lanosterol biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY66-420	carnosine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-46	putrescine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_MANNCAT-PWY	D-mannose degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6535	4-aminobutyrate degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6173	histamine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_GLNSYN-PWY	glutamine biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6535	4-aminobutanoate degradation I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6619	adenine and adenosine salvage II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY-6334	L-dopa degradation	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
HUMAN_PWY66-11	BMP Signalling Pathway	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000077	7.66664509654902e-13	1	0	0	115	907
META_PWY66-428	L-threonine degradation V	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY-5972	stearate biosynthesis I (animals and fungi)	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY66-378	androgen biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY-5143	fatty acid activation	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_ILEUDEG-PWY	L-isoleucine degradation I	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY-5996	oleate biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY66-428	threonine degradation	1.00000000000162	1.61757193934642e-12	6	0	0	115	907
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY66-374	C20 prostanoid biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY-5994	palmitate biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_PWY66-374	C20 prostanoid biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_PWY-5130	2-oxobutanoate degradation I	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY66-373	sucrose degradation	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_PWY-6369	inositol pyrophosphates biosynthesis	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
META_DETOX1-PWY-1	reactive oxygen species degradation	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_PWY-5130	2-oxobutanoate degradation	1.0000000000031	3.09618370223673e-12	7	0	0	115	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.0000000000037	3.69652786471922e-12	8	0	0	115	907
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.0000000000037	3.69652786471922e-12	8	0	0	115	907
HUMAN_PWY-7434	terminal O-glycans residues modification	1.0000000000037	3.69652786471922e-12	8	0	0	115	907
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	1.0000000000037	3.69652786471922e-12	8	0	0	115	907
HUMAN_PWY-6353	purine nucleotides degradation	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
HUMAN_PWY-7527	methionine salvage cycle III	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000557	5.57171530984273e-12	9	0	0	115	907
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000755	7.54742309103294e-12	10	0	0	115	907
META_PWY-922	mevalonate pathway I	1.00000000000755	7.54742309103294e-12	10	0	0	115	907
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000755	7.54742309103294e-12	10	0	0	115	907
HUMAN_PWY-922	mevalonate pathway	1.00000000000755	7.54742309103294e-12	10	0	0	115	907
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.00000000000755	7.54742309103294e-12	10	0	0	115	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000794	7.93806318118849e-12	11	0	0	115	907
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000000794	7.93806318118849e-12	11	0	0	115	907
HUMAN_PWY-5972	stearate biosynthesis	1.00000000000794	7.93806318118849e-12	11	0	0	115	907
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000794	7.93806318118849e-12	11	0	0	115	907
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	1.00000000000794	7.93806318118849e-12	11	0	0	115	907
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000001011	1.01070546774596e-11	12	0	0	115	907
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000001011	1.01070546774596e-11	12	0	0	115	907
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000001164	1.16350748659844e-11	13	0	0	115	907
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	1.00000000001164	1.16350748659844e-11	13	0	0	115	907
META_PWY66-409	superpathway of purine nucleotide salvage	1.00000000001164	1.16350748659844e-11	13	0	0	115	907
META_FAO-PWY	fatty acid beta-oxidation I	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
HUMAN_FAO-PWY	fatty acid beta-oxidation	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000001204	1.20417091470704e-11	14	0	0	115	907
